Ximbio

ximbio (www.ximbio.com) will change the way life science reagents are searched, sourced and shared. through ximbio researchers and technology transfer offices can virtually deposit their reagents to an online portal. each reagent record can be linked to the originating inventor, enabling scientists and institutions to be credited for their work. life science reagents companies can use ximbio to easily source new products to augment their portfolios via a straightforward commercialisation process. ximbio offers scientists looking for a specific reagent with a fully searchable database, extensive datasheets, peer reviews and supplier options. ximbio is owned by cancer research technology (crt). a share of product-based revenues is returned to the depositing institution. ximbio will focus on all areas of biology, and will broaden the range of tools available to scientists globally, to support and advance life science research.